265 related articles for article (PubMed ID: 24795363)
21. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis and clinical spectrum of primary sclerosing cholangitis.
Gidwaney NG; Pawa S; Das KM
World J Gastroenterol; 2017 Apr; 23(14):2459-2469. PubMed ID: 28465630
[TBL] [Abstract][Full Text] [Related]
23. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
25. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
[TBL] [Abstract][Full Text] [Related]
26. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
Kim YS; Hurley EH; Park Y; Ko S
Exp Mol Med; 2023 Jul; 55(7):1380-1387. PubMed ID: 37464092
[TBL] [Abstract][Full Text] [Related]
27. Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations.
Bowlus CL; Li CS; Karlsen TH; Lie BA; Selmi C
Liver Transpl; 2010 Nov; 16(11):1324-30. PubMed ID: 21031548
[TBL] [Abstract][Full Text] [Related]
28. The microbiota and the gut-liver axis in primary sclerosing cholangitis.
Hov JR; Karlsen TH
Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):135-154. PubMed ID: 36352157
[TBL] [Abstract][Full Text] [Related]
29. Genetics of primary sclerosing cholangitis and pathophysiological implications.
Jiang X; Karlsen TH
Nat Rev Gastroenterol Hepatol; 2017 May; 14(5):279-295. PubMed ID: 28293027
[TBL] [Abstract][Full Text] [Related]
30. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.
Stumme F; Steffens N; Steglich B; Mathies F; Nawrocki M; Sabihi M; Soukou-Wargalla S; Göke E; Kempski J; Fründt T; Weidemann S; Schramm C; Gagliani N; Huber S; Bedke T
Front Immunol; 2024; 15():1307297. PubMed ID: 38510236
[TBL] [Abstract][Full Text] [Related]
31. Primary sclerosing cholangitis.
Williamson KD; Chapman RW
Dig Dis; 2014; 32(4):438-45. PubMed ID: 24969292
[TBL] [Abstract][Full Text] [Related]
32. Novel developments in IBD-related sclerosing cholangitis.
Ponsioen CY
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S15-8. PubMed ID: 21640925
[TBL] [Abstract][Full Text] [Related]
33. Update on primary sclerosing cholangitis.
Karlsen TH; Schrumpf E; Boberg KM
Dig Liver Dis; 2010 Jun; 42(6):390-400. PubMed ID: 20172772
[TBL] [Abstract][Full Text] [Related]
34. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory Nodules Identify Steroid-Responsive Primary Sclerosing Cholangitis.
Chen JH; Deshpande V
Int J Surg Pathol; 2018 Aug; 26(5):402-409. PubMed ID: 29464971
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the genetic predisposition to primary sclerosing cholangitis.
Karlsen TH; Kaser A
Semin Liver Dis; 2011 May; 31(2):188-207. PubMed ID: 21538284
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
[No Abstract] [Full Text] [Related]
38. Primary sclerosing cholangitis.
Esber EJ; Ferguson DR
Gastroenterologist; 1994 Jun; 2(2):131-46. PubMed ID: 8055238
[TBL] [Abstract][Full Text] [Related]
39. Emerging treatments for primary sclerosing cholangitis.
Rodriguez EA; Carey EJ; Lindor KD
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):451-459. PubMed ID: 28276816
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Singh S; Loftus EV; Talwalkar JA
Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
